ESE
ESE: Abson Jeremy discloses securities transactions
Abson Jeremy reported Grant or award in ESCO TECHNOLOGIES INC: 167 units of Restricted Share Units (derivative), dated 2026-10-21. The full Form 4 contains 1 transaction entry.
ESE
Abson Jeremy reported Grant or award in ESCO TECHNOLOGIES INC: 167 units of Restricted Share Units (derivative), dated 2026-10-21. The full Form 4 contains 1 transaction entry.
ERIE
Novacek Jorie L reported Other (see filing) in ERIE INDEMNITY CO: 5.978 units of Incentive Compensation Deferral Plan Share Credits (derivative), dated 2026-10-20. The full Form 4 contains 1 transaction entry.
BULL
Denier Anthony Michael reported Sale in Webull Corp: 53846 units of Class A Ordinary Shares, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
ACN
Egawa Atsushi reported Grant or award in Accenture plc: 3194 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
ACN
Macchi Mauro reported Grant or award in Accenture plc: 3194 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Walsh John F reported Grant or award in Accenture plc: 10211 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Sharma Manish reported Grant or award in Accenture plc: 10211 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Park Angie Y reported Grant or award in Accenture plc: 793 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Unruch Joel reported Grant or award in Accenture plc: 8297 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Burgum Melissa A reported Grant or award in Accenture plc: 925 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Sweet Julie Spellman reported Grant or award in Accenture plc: 38302 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
ACN
Sekido Ryoji reported Grant or award in Accenture plc: 3194 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
UNTY
Maricondo Peter E reported Exercise or conversion in UNITY BANCORP INC /NJ/: 1600.00 units of Common Stock, dated 2026-10-20. The full Form 4 contains 3 transaction entries.
AGMB
Epstein David R reported Purchase in AgomAb Therapeutics NV: 5000 units of Common shares, dated 2026-10-21. The full Form 4 contains 2 transaction entries.
MBX
Radovich Peter reported Grant or award in MBX Biosciences, Inc.: 18200 units of Stock option (right to buy) (derivative), dated 2026-10-20. The full Form 4 contains 1 transaction entry.
UXIN
Dai Kun reported Purchase in Uxin Ltd: 4002 units of American depositary shares, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
BEKE
Peng Yongdong reported Other (see filing) in KE Holdings Inc.: 526428 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
BEKE
Shan Yigang reported Other (see filing) in KE Holdings Inc.: 228409 units of Class A ordinary shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
Rooder Brian James reported Purchase in Stone Point Credit Income Fund: 68.352 units of Common Shares, par value $0.001 per share, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
PLSM
Woods David reported Grant or award in Pulsenmore Ltd.: 6886 units of Options to Purchase Ordinary Shares (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
Williams Brian S reported Purchase in MSD Investment Corp.: 13129.501 units of Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
Henke Steven reported Purchase in Stone Point Credit Income Fund: 136.705 units of Common Shares, par value $0.001 per share, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
GXVIX
GLOBAL X MANAGEMENT COMPANY, INC. reported Purchase in Global X Venture & Innovation Fund: 1945525.292 units of Class I Shares of Beneficial Interest, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
FRANKLIN TEMPLETON INC reported Sale in Clarion Partners Real Estate Income Fund Inc.: 441696.113 units of Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.